Frederick W. Gluck - 16 Jun 2021 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Frederick W. Gluck
Issuer symbol
CTMX
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 18:43:51 UTC
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 16 Jun 2021 Common Stock 20,000 $7.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.